Does TECHNETIUM TC-99M OXIDRONATE Cause Injection site extravasation? 9 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 9 reports of Injection site extravasation have been filed in association with TECHNETIUM TC-99M OXIDRONATE. This represents 6.9% of all adverse event reports for TECHNETIUM TC-99M OXIDRONATE.
9
Reports of Injection site extravasation with TECHNETIUM TC-99M OXIDRONATE
6.9%
of all TECHNETIUM TC-99M OXIDRONATE reports
0
Deaths
2
Hospitalizations
How Dangerous Is Injection site extravasation From TECHNETIUM TC-99M OXIDRONATE?
Of the 9 reports, 2 (22.2%) required hospitalization.
Is Injection site extravasation Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TECHNETIUM TC-99M OXIDRONATE. However, 9 reports have been filed with the FAERS database.
What Other Side Effects Does TECHNETIUM TC-99M OXIDRONATE Cause?
Nausea (16)
Bone scan abnormal (15)
Headache (10)
Injection site pain (9)
Injection site erythema (8)
Injection site swelling (8)
Chest pain (7)
Pruritus (7)
Dizziness (6)
Drug ineffective (6)
What Other Drugs Cause Injection site extravasation?
EXENATIDE (2,320)
ETANERCEPT (1,139)
ADALIMUMAB (381)
SEMAGLUTIDE (342)
VEDOLIZUMAB (237)
SOMATROPIN (230)
REGADENOSON (226)
RITUXIMAB (215)
EVOLOCUMAB (188)
DUPILUMAB (170)
Which TECHNETIUM TC-99M OXIDRONATE Alternatives Have Lower Injection site extravasation Risk?
TECHNETIUM TC-99M OXIDRONATE vs TECHNETIUM TC-99M PERTECHNETATE
TECHNETIUM TC-99M OXIDRONATE vs TECHNETIUM TC-99M SESTAMIBI
TECHNETIUM TC-99M OXIDRONATE vs TECHNETIUM TC-99M TETROFOSMIN
TECHNETIUM TC-99M OXIDRONATE vs TECLISTAMAB
TECHNETIUM TC-99M OXIDRONATE vs TECLISTAMAB-CQYV